NCT01631474 - A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris | Biotech Hunter

Enrollment

363

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Acne Vulgaris

Interventions

DRUG

CB-03-01

Topical cream, applied once a day

DRUG

Vehicle

Topical cream, applied once or twice a day

DRUG

CB-03-01

Topical cream, applied twice a day

Trial Locations (13)

Penn State Milton S. Hershey Medical Center - Dept. of Dermatology, Hershey

Virginia Clinical Research, Norfolk

Gwinnett Clinical Research Center, Inc., Snellville

Indiana Clinical Trials Center, Plainfield

Altman Dermatology Associates, Arlington Heights

UT Houston Health Science Center, Houston

J & S Studies, College Station

Dermatology Research Associates, Los Angeles

Therapeutics Clinical Research, San Diego

University Clinical Trials, San Diego

International Clinical Research - US, LLC, Sanford

Marina I. Peredo, M.D., PC, Smithtown

Clinical Partners, LLC, Johnston